Open Access

Clinical value of microRNA‑198‑5p downregulation in lung adenocarcinoma and its potential pathways

  • Authors:
    • Shi‑Shuo Wang
    • Ye‑Ying Fang
    • Jia‑Cheng Huang
    • Yue‑Ya Liang
    • Yi‑Nan Guo
    • Lin‑Jiang Pan
    • Gang Chen
  • View Affiliations

  • Published online on: July 12, 2019     https://doi.org/10.3892/ol.2019.10610
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung adenocarcinoma (LUAD), the main subtype of non‑small cell lung cancer, is known to be regulated by various microRNAs (miRs/miRNAs); however, the role of miR‑198‑5p in LUAD has not been clarified. In the present study, the clinical value of miR‑198‑5p in LUAD and its potential molecular mechanism was evaluated. miR‑198‑5p expression was examined by reverse transcription‑quantitative PCR (RT‑qPCR) in 101 paired LUAD and adjacent normal lung tissues. Subsequently, the miR‑198‑5p expression level was determined from microarray data from the Gene Expression Omnibus, ArrayExpress and by meta‑analyses. Furthermore, the target mRNAs of miR‑198‑5p from 12 miRNA‑mRNA predictive tools were intersected with The Cancer Genome Atlas (TCGA)‑based differentially expressed genes. In addition, Gene Ontology annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted to determine the possible mechanism of miR‑198‑5p in LUAD. The Search Tool for the Retrieval of Interacting Genes/Proteins database was employed to construct a protein‑protein interaction network among the potential target genes of miR‑198‑5p. The results showed that miR‑198‑5p expression was lower in LUAD tissues than in adjacent non‑cancerous lung tissues (4.469±2.495 vs. 5.301±2.502; P=0.015). Meta‑analyses, including the data from the present study and online microarray data, also verified the downregulation of miR‑198‑5p in 584 cases of LUAD. The expression of miR‑198‑5p was associated with the age, blood vessel invasion, Tumor‑Node‑Metastasis stage, and lymph node metastasis of patients with LUAD and served as an independent prognostic factor for survival. The hub genes of miR‑198‑5p were upregulated in LUAD, according to TCGA and The Human Protein Atlas. For the KEGG pathway analysis, the most enriched KEGG pathway was the p53 signaling pathway (P=1.42x10‑6). These findings indicated that the downregulation of miR‑198‑5p may play a pivotal role in the development of LUAD by targeting various signaling pathways.

Related Articles

Journal Cover

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, S., Fang, Y., Huang, J., Liang, Y., Guo, Y., Pan, L., & Chen, G. (1899). Clinical value of microRNA‑198‑5p downregulation in lung adenocarcinoma and its potential pathways. Oncology Letters, 0, 0-0. https://doi.org/10.3892/ol.2019.10610
MLA
Wang, S., Fang, Y., Huang, J., Liang, Y., Guo, Y., Pan, L., Chen, G."Clinical value of microRNA‑198‑5p downregulation in lung adenocarcinoma and its potential pathways". Oncology Letters 0.0 (1899): 0-0.
Chicago
Wang, S., Fang, Y., Huang, J., Liang, Y., Guo, Y., Pan, L., Chen, G."Clinical value of microRNA‑198‑5p downregulation in lung adenocarcinoma and its potential pathways". Oncology Letters 0, no. 0 (1899): 0-0. https://doi.org/10.3892/ol.2019.10610